Granted Over $4.5 Million Federal Funding

Since its 2017 inception, In Vitro Diagnostic Solutions has successfully secured and executed over $4.5 million in federal funding from the National Institutes of Health and the National Science Foundation. Through these programs, we have successfully demonstrated strong scientific feasibility and launched commercialization of several innovative chemistries in a universal platform that will transform the market and increase accessibility for point of care diagnostics across a wide spectrum of challenge diseases.

Glucose-6-Phosphate Dehydrogenase (Phase I SBIR)

$191,220
Principal Investigator : Robert Harper Disease Indication : Malaria
Read More

Glucose-6-Phosphate Dehydrogenase (Phase II SBIR)

$1,447,330
Principal Investigator : Robert Harper Disease Indication: Malaria
Read More

Phenylalanine Determination (Phase I SBIR)

$224,700
Principal Investigator : Robert Harper Disease Indication : Phenylketonuria
Read More

Phenylalanine Determination (Phase II SBIR)

$1,946,957
Principal Investigator : Robert Harper Disease Indication : Phenylketonuria
Read More

Determination of the Bilirubin (Phase I SBIR)

$224,700
Principal Investigator : Robert Harper Disease Indication : Kernicterus
Read More

Simultaneous G6PD and Hemoglobin (Phase I SBIR)

$225,000
Principal Investigator : Robert Harper Disease Indication : Malaria
Read More

In Vitro Diagnostic Solutions is extremely grateful for the strong commercialization support provided by both the National Institute of Health and National Science Foundation Small Business Innovative Research Programs.

ABOUT IVDS
IVDS develops novel testing technologies for the healthcare, veterinary, and consumer markets. IVDS scientists have helped bring 10 FDA-approved products to market over their careers in diagnostics.
CONTACT INFO
  • In Vitro Diagnostic Solutions
    900 N. Lenola Rd., Bldg. 7, Unit L
    Moorestown, NJ 08057
  • (856)-343-5098
  • Robert@ivd.solutions